Market Tracker

08/29 2:00pm ET

PDL BioPharma Inc (NASDAQ:PDLI)

2.80
BATS BZX Real-Time Price
As of 1:59pm ET
 -0.06 / -2.10%
Today’s Change
2.58
Today|||52-Week Range
5.68
-20.90%
Year-to-Date
3 Horrible Stocks for Retirees
Aug 15 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close2.86
Today’s open2.82
Day’s range2.77 - 2.84
Volume48,869
Average volume (3 months)1,388,588
Market cap$473.4M
Dividend yield7.14%
Data as of 1:59pm ET, 08/29/2016

Growth & Valuation

Earnings growth (last year)+9.14%
Earnings growth (this year)-74.67%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+0.01%
P/E ratio2.0
Price/Sales0.99
Price/Book0.68

Competitors

 Today’s
change
Today’s
% change
BLCMBellicum Pharmaceuti...+0.21+1.21%
KDMNKadmon Holdings Inc-0.01-0.10%
EPZMEpizyme Inc-0.08-1.04%
ADAPAdaptimmune Therapeu...-0.08-1.12%
Data as of 2:00pm ET, 08/29/2016

Financials

Next reporting dateNovember 2, 2016
EPS forecast (this quarter)$0.08
Annual revenue (last year)$585.1M
Annual profit (last year)$332.8M
Net profit margin56.88%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Peter McLaughlin
Chief Financial Officer &
Vice President
Peter S. Garcia
Corporate headquarters
Incline Village, Nevada

Forecasts